Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nancy Pham

Digital Content Designer

Washington, DC

Nancy supports the Citeline editorial team with design and multimedia projects, including infographics, data visualizations, and UI/UX.

She holds a BA in Journalism and previously worked at US News & World Report as a digital producer. In her spare time, Nancy enjoys traveling, being outdoors, and attending concerts.

Latest From Nancy Pham

Big Pharma At US FDA: A Regulatory Scorecard

The breakthrough designations, approvals, and rejections for applications from the 15 biggest companies in a Pink Sheet infographic.

US FDA Performance Tracker Drug Review

Accelerated Approval: Gene Therapy Confirmatory Trial Timelines Can Stretch

Pink Sheet infographic looks at the nascent space of gene therapy accelerated approvals, where confirmatory trial timelines can run many years beyond approval due to disease rarity and a focus on durability of response.

Gene Therapy Review Pathway

The Ongoing Efforts To Confirm DMD Treatment Benefits

Infographic outlines the current status and history of several ongoing confirmatory trials for Duchenne muscular dystrophy treatments and a proposed gene therapy. Some have seen enrollment targets and eligibility requirements change over the years, along with the estimated completion dates.

Gene Therapy Post Market Regulation & Studies

Pink Sheet’s Top Seven Infographics Of 2022

From US drug pricing to Japan’s Sakigake expedited pathway, important regulatory developments and trends are easier to understand and track with Pink Sheet graphics.

Pink Sheet Perspectives Review Pathway

Alzheimer’s Disease Trial Designs Struggle To Turn Noise Into Sound

Infographic compares pivotal trials for Alzheimer's disease-modifying candidates from Biogen/Eisai, Lilly and Roche.

Clinical Trials Research & Development

Game Time: FDA Releases Review Timeline Goals Set By MDUFA V

This exclusive infographic shows new review timelines the FDA announced for FY 2023 now that MDUFA V has been ratified.

Policy FDA
See All